MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-10-0001447
Canbro Pharmaceuticals Private Limited - pharma in Karnal, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹1.46 Cr
Latest filing
Net profit · FY 2022
₹54,542
Net margin 0.4%
EBITDA · FY 2022
₹40.96 Lakh
EBITDA margin 28.1%
Authorised capital
₹70 Lakh
Registered with MCA
Paid-up capital
₹70 Lakh
Issued & subscribed
Open charges
₹1.6 Cr
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
3
As per MCA filings
About Canbro Pharmaceuticals Private Limited
Data last updated:
Canbro Pharmaceuticals Private Limited is a private limited company based in Karnal, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 June 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24304HR2019PTC080778. Its GSTIN is 06AAICC2193F1ZS (Haryana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹70 Lakh and a paid-up capital of ₹70 Lakh. It is led by directors including Manoj Malhotra and Parikshit Malhotra.
Its last annual general meeting (AGM) was held on 23 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot 374 Sector – 3 Extension, Karnal, Haryana, India – 132001.
As per the financials filed for FY 2022, the company reported a revenue of ₹1.46 Cr. For the same year it recorded a net profit of ₹54,542 (net margin 0.4%) and EBITDA of ₹40.96 Lakh (EBITDA margin 28.1%).
As per MCA filings, the company has open charges of ₹1.6 Cr on record. The company has 1 deal on record (1 funding round), with disclosed funding of ₹69 Lakh; the latest was in November 2019.
Canbro Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-10-0001447). For more details, the company can be reached via its website canbro.in.
Company details
CIN U24304HR2019PTC080778
Registration Number 080778
Incorporation Date 07 June 2019
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 23 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Small
Udyam Registration UDYAM-HR-10-0001447
Key People
Manoj Malhotra Director Parikshit Malhotra Director Dinesh Kumar Singh Additional Director Recognitions & Rankings of Canbro Pharmaceuticals
Contact details
Canbro Pharmaceuticals Private Limited's registered office is in Karnal, Haryana. Its website is canbro.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot 374 Sector – 3 Extension, Karnal, Haryana, India – 132001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Canbro Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Canbro Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Canbro Pharmaceuticals Private Limited
FY 2025 filings availableCanbro Pharmaceuticals Private Limited reported revenue of ₹1.46 Cr for FY 2022.
Revenue · FY 2022
₹1.46 Cr
Net profit · FY 2022
₹54,542 margin 0.4%
EBITDA · FY 2022
₹40.96 Lakh margin 28.1%
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹1.46 Cr | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹40.96 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹54,542 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 28.1% | ||
| Net Profit Margin | 0.4% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Canbro Pharmaceuticals Private Limited, buy the company report.
Board of directors of Canbro Pharmaceuticals Private Limited
Canbro Pharmaceuticals has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Malhotra | Director | 07 Jun 2019 | 7 Years 4 Months | Current |
| Parikshit Malhotra | Director | 07 Jun 2019 | 7 Years 4 Months | Current |
| Dinesh Kumar Singh | Additional Director | 20 Mar 2025 | 1 Years 7 Months | Current |
Auditor
Canbro Pharmaceuticals Private Limited is audited by S H S P AND ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S H S P AND ASSOCIATES | FY 2022 | 004267N |
Shareholding
The shareholding of Canbro Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Canbro Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.6 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Dec 2019 | 100312461 | Others | ₹60 Lakh | Open | |
| 31 Dec 2019 | 100312909 | Others | ₹1 Cr | Open |
Total charge records: 2 View all charges
Deals & funding
Canbro Pharmaceuticals Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹69 Lakh; the latest was in November 2019.
Total deals
1
Funding round
1
Disclosed funding
₹69 Lakh
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2019 | Funding round | ₹69 Lakh | Investors: Manoj Malhotra HUF, 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Canbro Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Canbro Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Canbro Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAICC2193F1ZS | Haryana | Active | 06 Aug 2019 |
To see the full GST registrations and return filing status of Canbro Pharmaceuticals Private Limited, buy the company report.
Recent activity
Canbro Pharmaceuticals Private Limited has 10 board changes on record since 2019: 5 appointments and 5 cessations. The latest: Dinesh Kumar Singh was appointed as Additional Director on 20 Mar 2025.
AGM
Canbro Pharmaceuticals Private Limited last Annual general meeting of members was held on 23 Sep 2025 as per latest MCA records.
Filing
Canbro Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Appointed
Dinesh Kumar Singh was appointed as Additional Director.
Ceased
Manish Kumar ceased to be Additional Director.
Ceased
Santkumar ceased to be Additional Director.
Appointed
Joginder Singh Rawat was appointed as Additional Director.
Appointed
Manish Kumar was appointed as Additional Director.
Ceased
Shambhu Kumar ceased to be Additional Director.
Ceased
Rewati Raman Rai ceased to be Additional Director.
Ceased
Sunil Kumar Jha ceased to be Director.
Charges
A charge with Others amounted to Rs. 60.00 Lakh with Charge ID 100312461 was registered on 31 Dec 2019.
Charges
A charge with Others amounted to Rs. 100.00 Lakh with Charge ID 100312909 was registered on 31 Dec 2019.
3 earlier events are in the company report.
Frequently asked questions
Canbro Pharmaceuticals is an active private limited company based in Karnal, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 June 2019 (7+ years old) and is registered under CIN U24304HR2019PTC080778.
Canbro Pharmaceuticals has 3 current directors:
- Manoj Malhotra - Director
- Parikshit Malhotra - Director
- Dinesh Kumar Singh - Additional Director
The latest financial statements of Canbro Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 23 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Canbro Pharmaceuticals is 06AAICC2193F1ZS, registered in Haryana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Canbro Pharmaceuticals is U24304HR2019PTC080778. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Canbro Pharmaceuticals was incorporated on 07 June 2019, making it 7+ years old. It is registered with the Registrar of Companies, Haryana.
Canbro Pharmaceuticals has 1 deal on record (1 funding round), with disclosed funding of ₹69 Lakh; the latest was in November 2019.
Dinesh Kumar Singh was appointed as Additional Director on 20 Mar 2025. Manish Kumar ceased to be Additional Director on 04 Jan 2025. Santkumar ceased to be Additional Director on 26 Apr 2024. Canbro Pharmaceuticals has 10 board changes on record in total.
Yes, Canbro Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-HR-10-0001447).
Canbro Pharmaceuticals can be reached through the website canbro.in. Its registered office is in Karnal, Haryana, India.